Prevention and Management of Common Adverse Effects of Ketamine and Esketamine in Patients with Mood Disorders.
Ceban F, Rosenblat JD, Kratiuk K, Lee Y, Rodrigues NB, Gill H, Subramaniapillai M, Nasri F, Lui LMW, Lipsitz O, Kumar A, Lee JG, Chau EH, Cao B, Lin K, Ho RC, Mansur RB, Swainson J, McIntyre RS.
Ceban F, et al. Among authors: lipsitz o.
CNS Drugs. 2021 Sep;35(9):925-934. doi: 10.1007/s40263-021-00846-5. Epub 2021 Aug 7.
CNS Drugs. 2021.
PMID: 34363603
Review.